Home › Funds › Eversept Partners, LP › VERA

Eversept Partners, LP position in VERA

VERA THERAPEUTICS INC · Health Care

Eversept Partners, LP reported holding 2,212,770 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$94.9M, representing 4.97% of its reported portfolio and ranking #5 among its reported holdings. Eversept Partners, LP has disclosed VERA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.21M sh
Reported value held$94.95M
Portfolio Weight4.97%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's VERA position evolved

Eversept Partners, LP first disclosed a stake in VERA in Q3 2023 at 1,478,489 shares (US$20.3M). The position peaked in Q4 2025 at 3,072,304 shares, worth US$155.6M. Across 12 filings, Eversept Partners, LP increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,212,770 shares valued at US$94.9M — an increase of 39,484 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2023 (shares rose 180% over the following quarter), a 26% increase in Q2 2025 (shares rose 23% over the following quarter), a 29% trim in Q1 2026 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.48M $20.27M New
Q4 2023 1.91M $29.45M Add
Q1 2024 1.82M $78.64M Reduce
Q2 2024 2.04M $73.92M Add
Q3 2024 2.05M $90.62M Hold
Q4 2024 1.60M $67.66M Reduce
Q1 2025 1.90M $45.61M Add
Q2 2025 2.38M $56.14M Add
Q3 2025 2.81M $81.60M Add
Q4 2025 3.07M $155.58M Add
Q1 2026 2.17M $87.43M Reduce
Q2 2026 2.21M $94.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VERA and 13F data

VERA (VERA THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VERA

All VERA fund holders →

FAQ

How long has Eversept Partners, LP held VERA?

Eversept Partners, LP has disclosed VERA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Eversept Partners, LP's current position in VERA?

As of Q2 2026, Eversept Partners, LP holds 2.21M shares of VERA (VERA THERAPEUTICS INC), valued at $94.95M, representing 4.97% of its reported portfolio and ranking #5.

Has Eversept Partners, LP been buying or selling VERA?

In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in VERA. The position peaked in Q4 2025 at 3.07M shares.

Which other funds hold VERA?

Other major institutional holders of VERA include Avoro Capital Advisors LLC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.